vs
Side-by-side financial comparison of ACTELIS NETWORKS INC (ASNS) and Prime Medicine, Inc. (PRME). Click either name above to swap in a different company.
ACTELIS NETWORKS INC is the larger business by last-quarter revenue ($1.4M vs $838.0K, roughly 1.6× Prime Medicine, Inc.). ACTELIS NETWORKS INC runs the higher net margin — -184.5% vs -5498.7%, a 5314.2% gap on every dollar of revenue. On growth, ACTELIS NETWORKS INC posted the faster year-over-year revenue change (28.6% vs -61.6%).
Actelis Networks Inc develops and manufactures high-performance broadband access networking solutions for telecom operators, enterprises and government entities. Its core products include Ethernet over copper systems delivering cost-effective high-speed connectivity over existing copper infrastructure, with key markets across North America, Europe and the Asia-Pacific.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
ASNS vs PRME — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $838.0K |
| Net Profit | $-2.5M | $-46.1M |
| Gross Margin | 35.1% | — |
| Operating Margin | -122.3% | -5800.5% |
| Net Margin | -184.5% | -5498.7% |
| Revenue YoY | 28.6% | -61.6% |
| Net Profit YoY | -40.1% | -9.0% |
| EPS (diluted) | $-5.08 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $838.0K | ||
| Q3 25 | $643.0K | $1.2M | ||
| Q2 25 | $941.0K | $1.1M | ||
| Q1 25 | $721.0K | $1.5M | ||
| Q4 24 | $1.1M | $2.2M | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $3.4M | $0 | ||
| Q1 24 | $726.0K | $591.0K |
| Q4 25 | $-2.5M | $-46.1M | ||
| Q3 25 | $-2.0M | $-50.6M | ||
| Q2 25 | $-1.9M | $-52.6M | ||
| Q1 25 | $-1.9M | $-51.9M | ||
| Q4 24 | $-1.8M | $-42.3M | ||
| Q3 24 | $-511.0K | — | ||
| Q2 24 | $-78.0K | $-55.3M | ||
| Q1 24 | $-2.0M | $-45.8M |
| Q4 25 | 35.1% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 32.4% | — | ||
| Q1 25 | 34.8% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | -122.3% | -5800.5% | ||
| Q3 25 | -300.0% | -4406.0% | ||
| Q2 25 | -188.4% | -4787.2% | ||
| Q1 25 | -251.3% | -3603.3% | ||
| Q4 24 | -154.0% | -2025.7% | ||
| Q3 24 | -12.5% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | -257.7% | -8179.5% |
| Q4 25 | -184.5% | -5498.7% | ||
| Q3 25 | -307.9% | -4129.1% | ||
| Q2 25 | -202.0% | -4716.7% | ||
| Q1 25 | -258.0% | -3568.8% | ||
| Q4 24 | -169.4% | -1936.6% | ||
| Q3 24 | -20.1% | — | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -273.6% | -7743.0% |
| Q4 25 | $-5.08 | $-0.22 | ||
| Q3 25 | $-0.17 | $-0.32 | ||
| Q2 25 | $-0.21 | $-0.41 | ||
| Q1 25 | $-0.22 | $-0.40 | ||
| Q4 24 | $-7.90 | $-0.31 | ||
| Q3 24 | $-0.09 | — | ||
| Q2 24 | $-0.01 | $-0.46 | ||
| Q1 24 | $-0.50 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $63.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.8M | $120.9M |
| Total Assets | $9.5M | $342.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $63.0M | ||
| Q3 25 | $1.5M | $71.4M | ||
| Q2 25 | $393.0K | $53.8M | ||
| Q1 25 | $1.1M | $91.9M | ||
| Q4 24 | $2.0M | $182.5M | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.4M | $55.6M | ||
| Q1 24 | $1.4M | $94.2M |
| Q4 25 | — | — | ||
| Q3 25 | $150.0K | — | ||
| Q2 25 | $150.0K | — | ||
| Q1 25 | $150.0K | — | ||
| Q4 24 | $150.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $148.0K | — |
| Q4 25 | $4.8M | $120.9M | ||
| Q3 25 | $3.0M | $161.8M | ||
| Q2 25 | $1.3M | $60.9M | ||
| Q1 25 | $2.6M | $106.9M | ||
| Q4 24 | $3.0M | $153.1M | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.1M | $196.6M | ||
| Q1 24 | $-1.7M | $243.8M |
| Q4 25 | $9.5M | $342.7M | ||
| Q3 25 | $6.9M | $385.0M | ||
| Q2 25 | $6.0M | $279.0M | ||
| Q1 25 | $7.1M | $328.2M | ||
| Q4 24 | $8.2M | $297.5M | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $8.4M | $259.7M | ||
| Q1 24 | $10.5M | $311.4M |
| Q4 25 | — | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-37.3M |
| Free Cash FlowOCF − Capex | — | $-37.5M |
| FCF MarginFCF / Revenue | — | -4480.4% |
| Capex IntensityCapex / Revenue | — | 34.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-167.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-37.3M | ||
| Q3 25 | $-2.4M | $-35.0M | ||
| Q2 25 | $-1.0M | $-41.4M | ||
| Q1 25 | $-2.2M | $-48.9M | ||
| Q4 24 | $-1.8M | $16.2M | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $-2.1M | $-45.5M | ||
| Q1 24 | $-203.0K | $-67.7M |
| Q4 25 | — | $-37.5M | ||
| Q3 25 | — | $-35.3M | ||
| Q2 25 | — | $-43.0M | ||
| Q1 25 | — | $-51.3M | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-47.4M | ||
| Q1 24 | $-204.0K | $-70.0M |
| Q4 25 | — | -4480.4% | ||
| Q3 25 | — | -2880.5% | ||
| Q2 25 | — | -3855.1% | ||
| Q1 25 | — | -3526.8% | ||
| Q4 24 | — | 662.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -28.1% | -11849.6% |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 141.0% | ||
| Q1 25 | — | 166.6% | ||
| Q4 24 | 0.0% | 82.0% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | 393.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASNS
| Europe Middle East And Africa | $1.1M | 83% |
| Other | $228.0K | 17% |
PRME
Segment breakdown not available.
